Related Experiment Video
Updated: Oct 26, 2025
07:29
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
19.8K
Proteases Regulate Cancer Stem Cell Properties and Remodel Their Microenvironment.
Anamarija Habič1,2, Metka Novak1, Bernarda Majc1,2
1Department of Genetic Toxicology and Cancer Biology, National Institute of Biology, Ljubljana, Slovenia.
Summary
Proteases impact cancer stem cells (CSCs), crucial for tumor growth and therapy resistance. Understanding these proteases is vital for developing effective glioblastoma treatments.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Proteolytic activity is altered in tumors and their microenvironment.
- Cancer stem cells (CSCs) are a therapy-resistant subpopulation responsible for tumor initiation.
- CSCs reside in specialized niches within the tumor microenvironment.
Purpose of the Study:
- To review the significance of proteases in regulating CSC activities.
- To focus on the role of proteases in glioblastoma, a type of brain tumor.
- To explore how proteases influence CSC invasiveness, intercellular interactions, and resistance to therapy.
Main Methods:
- Literature review focusing on proteases and cancer stem cells.
- Analysis of protease involvement in CSC migration and niche interactions.
- Examination of protease modulation of CSC properties contributing to therapy resistance.
Main Results:
- Proteases and their inhibitors are involved in CSC invasiveness and intercellular communication.
- Proteases enhance CSC resilience to immunotherapy, irradiation, and chemotherapy.
- Proteases degrade the extracellular matrix, facilitating CSC migration.
- Proteases can modulate CSC properties, hindering their elimination.
Conclusions:
- Proteases play multifaceted roles in regulating cancer stem cells, particularly in glioblastoma.
- Targeting proteases requires a thorough understanding of their complex functions in CSCs.
- Investigating protease-oriented therapies is crucial for overcoming CSC-mediated treatment resistance.
Related Concept Videos
02:40Cancer Stem Cells and Tumor Maintenance
5.1K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.1K
02:17The Tumor Microenvironment
7.1K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.1K
02:53Adaptive Mechanisms in Cancer Cells
6.1K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.1K
03:03mTOR Signaling and Cancer Progression
4.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.0K
01:26Stem Cell Niche
5.6K
The stem cell niche is the dynamic microenvironment where stem cells reside. Inside these niches, the cells may remain undifferentiated, undergo high self-renewal, or become lineage-specific progenitors. Stem cells coexist with other niche cells, such as stromal cells. They also interact closely with the ECM. Cell-cell and cell-matrix communication occur via adhesion molecules or soluble factors that signal the stem cells and determine their fate. Stromal cells also provide survival signals to...
5.6K
01:35Cancer Cell Migration through Invadopodia
2.5K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.5K